These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8354118)

  • 1. Consensus review of the clinical utility of DNA cytometry in bladder cancer. Report of the DNA Cytometry Consensus Conference.
    Wheeless LL; Badalament RA; de Vere White RW; Fradet Y; Tribukait B
    Cytometry; 1993; 14(5):478-81. PubMed ID: 8354118
    [No Abstract]   [Full Text] [Related]  

  • 2. Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast. Report of the DNA Cytometry Consensus Conference.
    Hedley DW; Clark GM; Cornelisse CJ; Killander D; Kute T; Merkel D
    Cytometry; 1993; 14(5):482-5. PubMed ID: 8354119
    [No Abstract]   [Full Text] [Related]  

  • 3. Consensus review of the clinical utility of DNA flow cytometry in colorectal cancer.
    Bauer KD; Bagwell CB; Giaretti W; Melamed M; Zarbo RJ; Witzig TE; Rabinovitch PS
    Cytometry; 1993; 14(5):486-91. PubMed ID: 8354120
    [No Abstract]   [Full Text] [Related]  

  • 4. Consensus review of the clinical utility of DNA content cytometry in prostate cancer.
    Shankey TV; Kallioniemi OP; Koslowski JM; Lieber ML; Mayall BH; Miller G; Smith GJ
    Cytometry; 1993; 14(5):497-500. PubMed ID: 8354122
    [No Abstract]   [Full Text] [Related]  

  • 5. DNA image cytometry in bladder cancer: state of the art.
    Palmeira CA; Oliveira PA; Seixas F; Pires MA; Lopes C; Santos L
    Anticancer Res; 2008; 28(1B):443-50. PubMed ID: 18383883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colony formation in urinary bladder carcinoma. Relationship to DNA flow cytometry, stage and histopathology.
    Jacobsen AB; Tveit KM; Pettersen EO; Fossa SD; Ous S
    Anticancer Res; 1991; 11(2):777-81. PubMed ID: 2064333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Origins and clinical implications of aneuploidy in early bladder cancer.
    Shackney SE; Berg G; Simon SR; Cohen J; Amina S; Pommersheim W; Yakulis R; Wang S; Uhl M; Smith CA
    Cytometry; 1995 Dec; 22(4):307-16. PubMed ID: 8749781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA ploidy analysis of invasive bladder cancer by flow cytometry.
    Badalament RA; Smith JJ; Franklin GL; Drago JR
    In Vivo; 1990; 4(4):269-72. PubMed ID: 2103372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Flow cytometry in cancer of the bladder].
    Chassevent A; Allain YM; Chautard D; Larra F; Lépinard V; Soret JY
    Cancer Radiother; 1998 Apr; 2 Suppl 1():12s-15s. PubMed ID: 9749070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [DNA ploidy and cell cycle phase analysis with flow cytometry in bladder wash. Preliminary experience].
    Rivas del Fresno M; Salas Bustamante A; Suárez González JA; Tardón García A; Sampedro Nuño A
    Arch Esp Urol; 2000; 53(1):29-36. PubMed ID: 10730422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consensus review of the clinical utility of DNA flow cytometry in neoplastic hematopathology.
    Duque RE; Andreeff M; Braylan RC; Diamond LW; Peiper SC
    Cytometry; 1993; 14(5):492-6. PubMed ID: 8354121
    [No Abstract]   [Full Text] [Related]  

  • 12. [Contribution of cell cycle and DNA content study by flow cytometry in the prognosis of superficial bladder cancer: Tunisian experience].
    Bounemra-Benghanem A; Amri MA; Rammeh-Rommani S; Chebil M; Zermani R; Ben Jilani S; Jenhani F
    Ann Biol Clin (Paris); 2007; 65(1):41-9. PubMed ID: 17264038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA flow cytometry: an update of its use in assessing prognosis for transitional cell cancer of the bladder.
    Norming U
    Semin Urol; 1993 Aug; 11(3):154-63. PubMed ID: 8210836
    [No Abstract]   [Full Text] [Related]  

  • 14. Bivariate analysis DNA/cytokeratin 7 and flow cytometric measurement of MIB-1 in superficial transitional carcinoma of the bladder (TCC). Methodological aspects and prognostic implications.
    Leonardi E; Cristofori A; Reich A; Dalla Palma P
    Eur J Histochem; 1997; 41 Suppl 2():133-4. PubMed ID: 9859817
    [No Abstract]   [Full Text] [Related]  

  • 15. [Studies on nuclear DNA content in bladder cancers using flow cytometry].
    Toyota K
    Hokkaido Igaku Zasshi; 1996 Jan; 71(1):45-53. PubMed ID: 8727374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of cell deoxyribonucleic acid content measured by flow cytometry in bladder cancer.
    Bittard H; Lamy B; Billery C
    J Urol; 1996 Jun; 155(6):1887-91. PubMed ID: 8618280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of flow cytometry in the management of bladder cancer.
    Walther PJ
    Hematol Oncol Clin North Am; 1992 Feb; 6(1):81-98. PubMed ID: 1556054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA Cytometry Consensus Conference. Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast.
    Hedley DW; Clark GM; Cornelisse CJ; Killander D; Kute T; Merkel D
    Breast Cancer Res Treat; 1993 Oct; 28(1):55-9. PubMed ID: 8123870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic accuracy of urinary cytology, and deoxyribonucleic acid flow cytometry and cytology on bladder washings during followup for bladder tumors.
    Grégoire M; Fradet Y; Meyer F; Têtu B; Bois R; Bédard G; Charrois R; Naud A
    J Urol; 1997 May; 157(5):1660-4. PubMed ID: 9112500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of DNA flow cytometry in stomach cancer: a 5-year prospective study.
    Lee KH; Lee JS; Lee JH; Kim SW; Suh C; Kim WK; Kim SH; Min YI; Kim BS; Park KC; Lee MS; Sun HS
    Br J Cancer; 1999 Apr; 79(11-12):1727-35. PubMed ID: 10206284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.